From alvarezandmarsal.com: Rising cost pressures and advancements in therapeutics are driving demand for efficiency in drug development, creating opportunities for Contract Research Organisations.

The APAC region is emerging as a significant hub for clinical R&D, with market growth projected from $13 billion in 2025 to $35 billion by 2034.